In addition, along with function recovery (Figure 11), BPC 157 counteracts muscle disability related to various noxious procedures, after abdominal aorta anastomosis (Hrelec et al., 2009), L2-L3 compression (Perovic et al., 2019), severe electrolytes disturbances (Baric et al., 2016
Once reconstituted for in-vitro use, refrigerate and use within 3045 days
Results can approach professional treatments with proper technique and quality devices
BPC-157 is a synthetic 15-amino acid peptide derived from human gastric juice that demonstrates significant wound healing properties in preclinical research
Injectable forms linger longer in the system due to broader distribution and slower degradation , particularly when injected intramuscularly
The BPC-157 peptide is documented in peer-reviewed literature as acting through at least two distinct, non-redundant molecular pathways simultaneously which may explain its unusually broad tissue-repair activity profile